Cargando…

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

INTRODUCTION: It is important to confirm the effectiveness and tolerability of disease-modifying treatments for relapsing–remitting multiple sclerosis (RRMS) in real-world treatment settings. This prospective observational cohort study (VIRGILE) was performed at the request of the French health auth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papeix, Caroline, Castelnovo, Giovanni, Leray, Emmanuelle, Coustans, Marc, Levy, Pierre, Visy, Jean-Marc, Kobelt, Gisela, Lamy, Fabienne, Allaf, Bashar, Heintzmann, François, Chouette, Isabelle, Raponi, Eric, Durand, Barbara, Grevat, Emmanuelle, Kamar, Driss, Debouverie, Marc, Lebrun-Frenay, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095796/ https://www.ncbi.nlm.nih.gov/pubmed/35147904 http://dx.doi.org/10.1007/s40120-022-00334-y

Ejemplares similares

Virgil’s aeneid /
por: Virgilio
Publicado: (1909)

The plants of Virgil's Georgics
por: Abbe, Elfriede Martha, 1919
Publicado: (1965)

Evidence for a two-stage disability progression in multiple sclerosis
por: Leray, Emmanuelle, et al.
Publicado: (2010)

Dr. Virgil O. Hardon
Publicado: (1904)

The Death of Dr. Virgil O. Hardon
Publicado: (1904)

On the Death of Dr. Virgil O. Hardon
por: Wolff, Bernard, et al.
Publicado: (1904)

Oeuvres de Virgile : traduction française de la collection panckouke
por: Virgilio

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
por: Barbin, Laetitia, et al.
Publicado: (2016)

Resolutions Adopted on the Death of Dr. Virgil O. Hardon
por: Westmoreland, Willis F., et al.
Publicado: (1904)

Biographical Sketch: Virgil Pendelton Gibney, MD, 1847–1927
por: Brand, Richard A.
Publicado: (2009)

Liberty Bell 7: the suborbital Mercury flight of Virgil I. Grissom
por: Burgess, Colin
Publicado: (2014)

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
por: Leray, Emmanuelle, et al.
Publicado: (2015)

Serology results after COVID vaccine in multiple sclerosis patients treated with fingolimod
por: Ciccone, A., et al.
Publicado: (2023)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
por: Tourbah, Ayman, et al.
Publicado: (2016)

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
por: Roux, Thomas, et al.
Publicado: (2017)

The works of Virgil in English verse : the Aeneid translated by the Rev. Mr. Christopher Pitt, the Eclogues and Georgics, with notes on the whole, by the Rev. Mr. Joseph Warton : with several new observations by Mr. Holdsworth, Mr. Spence, and others : also, A dissertation on the sixth book of the Aeneid, by Mr. Warburton, On the shield of Aeneas, by Mr. W. Whitehead, On the character of Iapis, by the late Dr. Atterbury, Bishop of Rochester, and, Three essays on pastoral, didactic and epic poetry, by the editor : in four volumes
por: Virgilio
Publicado: (1763)

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
por: Wilson, Sarah, et al.
Publicado: (2022)

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
por: Pivot, Diane, et al.
Publicado: (2016)

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
por: Tourbah, Ayman, et al.
Publicado: (2018)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study
por: Garaix, Florentine, et al.
Publicado: (2018)

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament‐light chain in multiple sclerosis
por: Gauthier, Audrey, et al.
Publicado: (2021)

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study
por: Arnold, Douglas L, et al.
Publicado: (2020)

Pregnancy-related healthcare utilization among women with multiple sclerosis
por: Mainguy, Marie, et al.
Publicado: (2023)

Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod?
por: Bigaud, Marc, et al.
Publicado: (2023)

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
por: Laplaud, David-Axel, et al.
Publicado: (2019)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019)

Fulminant MS Reactivation Following Combined Fingolimod Cessation and Yellow Fever Vaccination
por: Rolfes, Leoni, et al.
Publicado: (2019)

Letter to the editor on “new algorithmic approach for easier and faster extended disability status scale calculation”
por: Cohen, Mikael, et al.
Publicado: (2023)

Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France
por: Gbaguidi, Brigitte, et al.
Publicado: (2022)

Performance of administrative databases for identifying individuals with multiple sclerosis
por: Ducatel, Pauline, et al.
Publicado: (2023)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
por: Sinnecker, Tim, et al.
Publicado: (2016)

Power management for Internet of Everything
por: Coustans, Mathieu, et al.
Publicado: (2018)

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
por: Lefort, M., et al.
Publicado: (2022)

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis
por: Brochet, Bruno, et al.
Publicado: (2017)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Covid-19, the pandemic war: Implication for neurologists
por: de Seze, J., et al.
Publicado: (2020)

Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
por: Krupp, Lauren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aan010m5nngf37lkla804alec5